Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03487874Completed
Randomised trial of ropivacaine in shoulder pain (2 arms), sponsored by Daegu Catholic University Medical Center. Primary endpoint: Pain intensity upon the introduction of a posterior portal. Started Apr 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03487874.